Press Releases Year None202020192018201720162015 Mar 30, 2020 Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome Mar 11, 2020 Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020 Mar 05, 2020 Ovid Therapeutics Announces Multiple Presentations at the American Academy of Neurology 2020 Annual Meeting Mar 02, 2020 Ovid Therapeutics Names Alexander Kolevzon, M.D., to Scientific Advisory Board Feb 25, 2020 Ovid Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference Pagination Current page 1 Page 2 Next page next › Last page last »
